LifeVantage Co. (NASDAQ:LFVN – Get Free Report) declared a quarterly dividend on Wednesday, February 5th,RTT News reports. Shareholders of record on Monday, March 3rd will be paid a dividend of 0.04 per share on Monday, March 17th. This represents a $0.16 annualized dividend and a yield of 0.70%.
LifeVantage has a payout ratio of 15.4% indicating that its dividend is sufficiently covered by earnings.
LifeVantage Stock Performance
Shares of LifeVantage stock traded down $1.00 on Wednesday, reaching $22.74. The company had a trading volume of 486,894 shares, compared to its average volume of 270,076. The firm’s 50 day moving average price is $18.97 and its two-hundred day moving average price is $13.59. LifeVantage has a 52-week low of $5.22 and a 52-week high of $27.38. The firm has a market cap of $284.70 million, a PE ratio of 71.06 and a beta of 0.84.
Analysts Set New Price Targets
LFVN has been the subject of several research reports. Craig Hallum began coverage on LifeVantage in a research report on Tuesday, January 14th. They issued a “buy” rating and a $35.00 target price for the company. Lake Street Capital started coverage on shares of LifeVantage in a report on Thursday, December 19th. They issued a “buy” rating and a $26.00 price objective for the company.
Get Our Latest Report on LifeVantage
About LifeVantage
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Featured Stories
- Five stocks we like better than LifeVantage
- Using the MarketBeat Dividend Tax Calculator
- 3 Must-Have ETFs Set to Dominate This Quarter
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Which Wall Street Analysts are the Most Accurate?
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.